(MedPage Today) — The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk prediction from screening mammograms.
The program, called Clairity Breast, analyzes mammograms for subtle…
Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/115858
Author :
Publish date : 2025-06-02 18:08:00
Copyright for syndicated content belongs to the linked Source.
